EUVIMEDEUVIMED entdecken
Crossref

Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia

Mehmet Yilmaz iD, Volkan Karakuş iD, Egemen Kaya iD, Nevruz İlhanlı iD, Bülent Huddam iD

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Mehmet Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of İnternal Medicine, Yunus Emre State Hospital, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Hematinics, Erythropoietin, Anemia, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Treatment with erythropoietin‐stimulating agents (ESAs) is widely used in anemia of chronic kidney disease (CKD). Acquired ESA resistance is an important problem. The aim of this study is to examine the bone marrow findings in hemodialysis patients with ESA‐resistant anemia.

Methods

The data of 210 patients with acquired ESA resistance were reviewed retrospectively. The patients were divided into groups according to having diagnosis of dysplasia and hematological disease, and survival analysis was performed.

Results

A total of 26 patients were included in the study. While dysplasia was present in 10 (38.5%) patients, five of them were diagnosed hematologically. When survival analysis was performed between those with and without a hematological diagnosis, a difference in survival was observed against the group with the diagnosis (24.4 vs. 72 months, p = 0.045).

Conclusion

Unresponsiveness to ESA treatment in CKD patients or a decrease in one of the other cell lines along with hemoglobin, it would be appropriate to perform early bone marrow examination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematinicsErythropoietinAnemiaRenal Insufficiency, ChronicHumansRetrospective StudiesBone MarrowRenal DialysisHemoglobins

Stichwörter der Autor:innen

anemiabone marrow findingschronic kidney diseasehemodialysis patientsunresponsiveness to erythropoiesis-stimulating agents

Substanzen

HematinicsErythropoietinHemoglobins

Autor:innen und Institutionen

  • Department of İnternal Medicine, Yunus Emre State Hospital, Eskişehir, Turkey.
  • Department of Internal Diseases, Division of Hematology, University of Health Sciences, Antalya Training & Research Hospital, Antalya, Turkey.
  • Department of Physiology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, Turkey.
  • Department of Biostatistics and Medical Informatics, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Department of Nephrology, Faculty of Medicine, Mugla Sıtkı Koçman University, Mugla, Turkey.

ORCID-Profile: Mehmet Yilmaz, Volkan Karakuş, Egemen Kaya, Nevruz İlhanlı, Bülent Huddam

Zitieren

APA

Yilmaz, M., Karakuş, V., Kaya, E., İlhanlı, N., & Huddam, B. (2024). Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14086

Vancouver

Yilmaz M, Karakuş V, Kaya E, İlhanlı N, Huddam B. Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14086

BibTeX
@article{Yilmaz2024,
  author = {Yilmaz, Mehmet and Karakuş, Volkan and Kaya, Egemen and İlhanlı, Nevruz and Huddam, Bülent},
  title = {Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14086}
}
Kostenlos starten →